Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Amedica Corporation (OTC: AMDA).

Full DD Report for AMDA

Recent News from (OTC: AMDA)

Amedica Announces Patent Grant for Silicon Nitride and Other Ceramic Materials
SALT LAKE CITY, March 30, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, is pleased to announce the issuance of a key material and process patent.  ...
Source: GlobeNewswire
Date: March, 30 2018 09:00
Amedica Granted Extension by NASDAQ to Regain Compliance with NASDAQ Listing Rule
SALT LAKE CITY, March 15, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, announced today that it received notification from the Listing Qualifications de...
Source: GlobeNewswire
Date: March, 15 2018 09:00
Midday Gainers / Losers (3/6/2018)
Gainers: ACMR +48% . ZSAN +49% . AMDA +30% . CHUBA +23% . BZUN +21% . OTCQX:CKPT +20% . CLSD +18% . AMRC +17% . GNCA +15% . INPX +15% . More news on: ACM Research, Inc., Zosano Pharma, Amedica Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: March, 06 2018 12:45
FDA OKs Amedica's Valeo C+CsC spinal fusion implant; shares up 34%
The FDA grants 510(k) clearance for Amedica's ( AMDA +33.5% ) Valeo C+CsC with Lumen Interbody Fusion Device composite spinal fusion implant. More news on: Amedica Corporation, Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: March, 06 2018 10:31
Premarket Gainers as of 9:05 am (03/06/2018)
AMDA +50%  on FDA clearance of the Valeo C+CsC with Lumen Interbody Fusion Device. More news on: Amedica Corporation, Caladrius Biosciences, Inc., CommerceHub, Inc., , Stocks on the move, Read more ...
Source: SeekingAlpha
Date: March, 06 2018 09:11
Amedica announces FDA Clearance of the Valeo C+CSC with Lumen Interbody Fusion Device
SALT LAKE CITY, UT, March 06, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride as a platform for biomedical applications, is pleased to announce the U.S. Food and Drug Administration (FDA) clearan...
Source: GlobeNewswire
Date: March, 06 2018 09:00
AMEDICA Announces Participation in Australian Spine Conference
SALT LAKE CITY, UT, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications, is pleased to announce that it has been invited to present at the 29th Annual Scientific ...
Source: GlobeNewswire
Date: February, 27 2018 09:00
AMEDICA PROVIDES BUSINESS UPDATE
SALT LAKE CITY, UT, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications, today provided a business update related to its business strategy and certain recent deve...
Source: GlobeNewswire
Date: January, 25 2018 09:00
Blog Exposure - Hologic Gets FDA Clearance for Quantra(TM) 2.2 Breast Density Assessment Software
Stock Monitor: Amedica Post Earnings Reporting LONDON, UK / ACCESSWIRE / November 28, 2017 / Active-Investors issued a free report on Hologic, Inc. (NASDAQ: HOLX ), which is readily accessible upon registration at www.active-investors.com/registration-sg/?symbol=HOLX as the Company'...
Source: ACCESSWIRE IA
Date: November, 28 2017 07:50
Your Daily Pharma Scoop: Synergy In 2018, Repatha Action Date, Alkermes Signs Deal
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Synergy Pharma Today we will critique ...
Source: SeekingAlpha
Date: November, 28 2017 07:43

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-241.451.381.451.350130,982
2018-04-231.441.421.4511.3534,734
2018-04-221.4811.451.501.4525,823
2018-04-211.4811.451.501.4525,823
2018-04-201.4811.451.501.4525,823

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

Short Analysis provided by Squeeze Report.


About Amedica Corporation (OTC: AMDA)

Logo for Amedica Corporation (OTC: AMDA)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $5,288,628 - 03/20/2018
  • Issue and Outstanding: 3,022,073 - 11/14/2017

 


Recent Filings from (OTC: AMDA)

Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 06 2018
General form for registration of securities under the Securities Act of 1933
Filing Type: S-1Filing Source: edgar
Filing Date: February, 14 2018
Post-effective amendment to an S-Type filing
Filing Type: POS AMFiling Source: edgar
Filing Date: February, 05 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: February, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 01 2018
Post-effective amendment to an S-Type filing
Filing Type: POS AMFiling Source: edgar
Filing Date: January, 19 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 04 2018
Amendment to a previously filed 10-Q
Filing Type: 10-Q/AFiling Source: edgar
Filing Date: December, 29 2017

 

 


Daily Technical Chart for (OTC: AMDA)

Daily Technical Chart for (OTC: AMDA)


Stay tuned for daily updates and more on (OTC: AMDA)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AMDA)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AMDA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of AMDA and does not buy, sell, or trade any shares of AMDA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us